Literature DB >> 15322197

Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium.

Mayumi Ueta1, Tomonori Nochi, Myoung-Ho Jang, Eun Jeong Park, Osamu Igarashi, Ayako Hino, Satoshi Kawasaki, Takashi Shikina, Takachika Hiroi, Shigeru Kinoshita, Hiroshi Kiyono.   

Abstract

Epithelial cells are key players in the first line of defense offered by the mucosal immune system against invading pathogens. In the present study we sought to determine whether human corneal epithelial cells expressing Toll-like receptors (TLRs) function as pattern-recognition receptors in the innate immune system and, if so, whether these TLRs act as a first line of defense in ocular mucosal immunity. Incubation of human primary corneal epithelial cells and the human corneal epithelial cell line (HCE-T) with peptidoglycan or LPS did not lead to activation, at the level of DNA transcription, of NF-kappaB or the secretion of inflammation-associated molecules such as IL-6, IL-8, and human beta-defensin-2. However, when incubated with IL-1alpha to activate NF-kappaB, the production by these cells of such inflammatory mediators was enhanced. Human corneal epithelial cells were observed to express both TLR2- and TLR4-specific mRNA as well as their corresponding proteins intracellularly, but not at the cell surface. However, even when LPS was artificially introduced into the cytoplasm, it did not lead to the activation of epithelial cells. Taken together, our results demonstrate that the intracellular expression of TLR2 and TLR4 in human corneal epithelial cells fails to elicit innate immune responses and therefore, perhaps purposely, contributes to an immunosilent environment at the ocular mucosal epithelium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322197     DOI: 10.4049/jimmunol.173.5.3337

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Toll-like receptors in ocular surface disease.

Authors:  Rachel L Redfern; Alison M McDermott
Journal:  Exp Eye Res       Date:  2010-03-24       Impact factor: 3.467

Review 2.  Host-pathogen interactions in the cornea.

Authors:  Takashi Suzuki; Ai Yamada; Michael S Gilmore
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

Review 3.  Innate immunity of the ocular surface.

Authors:  Shigeru Kinoshita; Mayumi Ueta
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

4.  Checks and balances: the ocular response to infection.

Authors:  Michelle C Callegan
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

Review 5.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 6.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

7.  Antigen capture of Porphyromonas gingivalis by human macrophages is enhanced but killing and antigen presentation are reduced by endotoxin tolerance.

Authors:  Manoj Muthukuru; Christopher W Cutler
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

Review 8.  Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease.

Authors:  J H Chang; P J McCluskey; D Wakefield
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

9.  Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation.

Authors:  Holly R Chinnery; Eric C Carlson; Yan Sun; Michelle Lin; Sandra H Burnett; Victor L Perez; Paul G McMenamin; Eric Pearlman
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

10.  Lack of MD-2 expression in human corneal epithelial cells is an underlying mechanism of lipopolysaccharide (LPS) unresponsiveness.

Authors:  Jing Zhang; Ashok Kumar; Michelle Wheater; Fu-Shin X Yu
Journal:  Immunol Cell Biol       Date:  2008-10-21       Impact factor: 5.126

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.